Literature DB >> 194728

Angiotensin (A I, A II, A III) receptor characterization. Correlation of prostaglandin release with peptide degradation.

A L Blumberg, K Nishikawa, S E Denny, G R Marshall, P Needleman.   

Abstract

We examined the ability of the angiotensins (A I, A II, A III) to release a prostaglandin E (PGE)-like substance in the isolated Krebs' perfused kidney and mesenteric vasculature of the rabbit by parallel bioassay. In the kidney, the order of potency for PGE release was A II greater than A III greater than A I with ED50's of 36, 100, and 500 pmol, respectively. In the mesenteric preparation, on the other hand, the order of potency was A III greater than A II greater than A I with ED50's of 75, 125, and 500 pmol, respectively. During one transit through the kidney 72-76% of bioassayable A I and A II was degraded. A III was 89% metabolized. In contrast, the mesenteric vasculature inactivated only 27% of A II and 23% of A III. This data suggests an inverse relationship between renal peptide degradation and PGE release. For characterization of the renal angiotensin receptor-mediating PGE release, dissociation constants (KB) of the competitive angiotensin antagonists [IIe7]-A III and [Sar1, IIe3]-A II were determined with each angiotensin. KB values of the individual antaganists were not significantly different with A I, A II, or A III; this finding suggests that one renal angiotensin receptor is involved with PGE release.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 194728     DOI: 10.1161/01.res.41.2.154

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  2 in total

1.  Angiotensin III-induced modulation of neurogenic responses in the rabbit vas deferens and portal vein.

Authors:  G J Trachte; E J Sybertz; M Michener; S B Binder; M J Peach
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-07       Impact factor: 3.000

2.  Attenuation of angiotensin II- and III-induced aldosterone release by prostaglandin synthesis inhibitors.

Authors:  W B Campbell; C E Gomez-Sanchez; B V Adams; J M Schmitz; H D Itskovitz
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.